文献速递细菌感染、耐药与抗菌药物医院感染防控

血流感染快速分子诊断的临床影响:随机对照试验

Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial.
PubMed 文献 · Clin Infect Dis · 2026-08-20

该随机对照试验将418例血培养阳性患者1:1分为标准护理组与标准护理联合BioFire BCID2多重PCR组,两组均实施抗菌药物管理。多重PCR组首次有效抗菌药物调整的中位时间显著缩短(23.2 vs 64.5小时,P<0.001),且持续血流感染率更低(5.7% vs 11.5%,P=0.038),但30天死亡率与住院时间无显著差异。

要点

  • 多重PCR显著缩短首次有效抗菌药物调整时间至23.2小时。
  • 多重PCR组持续血流感染率更低(5.7% vs 11.5%)。
  • 30天死亡率与住院时间两组无显著差异。

核心结论

  • 在血流感染患者中,快速多重PCR可缩短至有效抗菌药物调整的时间,并降低持续血流感染率,但未显著改善30天死亡率或住院时间。

研究设计与样本

  • 随机对照试验,418例血培养阳性患者1:1随机分为标准护理组(208例)和标准护理联合BioFire BCID2多重PCR组(210例),两组均实施抗菌药物管理。

主要发现

  • 多重PCR组首次有效抗菌药物调整中位时间显著短于标准护理组(23.2 vs 64.5小时,P<0.001)。
  • 革兰阴性菌(30.5 vs 77.1小时,P<0.001)、革兰阳性菌(22.7 vs 53.5小时,P=0.001)和酵母菌(2.9 vs 27.7小时,P<0.001)亚组中多重PCR组时间均显著缩短。
  • 无论实验室工作时间(常规时段:9.3 vs 66.7小时;非常规时段:37.5 vs 60.5小时,P<0.001)或ICU状态(ICU:20.5 vs 84.8小时,P<0.001;非ICU:23.4 vs 55.5小时,P<0.001),多重PCR组时间缩短均维持。
  • 多重PCR组持续血流感染率显著低于标准护理组(5.7% vs 11.5%,P=0.038)。
  • 30天死亡率和住院时间两组无显著差异。

临床怎么用

  • 对于血培养阳性患者,在抗菌药物管理框架下加用BioFire BCID2多重PCR可加速有效抗菌药物调整并减少持续血流感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rapid identification of pathogens and antimicrobial resistance is important for optimizing therapies for bloodstream infections. We conducted a randomized controlled trial comparing standard of care (SOC) culture and phenotypic antimicrobial susceptibility testing with SOC plus BioFire BCID2 testing (Multiplex PCR arm). METHODS: Patients with positive blood cultures were randomized 1:1 to the SOC or multiplex PCR arm, both with antimicrobial stewardship. The primary outcome was the time from randomization to the first effective antimicrobial modification within 120 h. The secondary outcomes were persistent bloodstream infections, mortality, and length of hospital stay. RESULTS: Among 418 patients (208 SOC, 210 multiplex PCR), the median time to first effective antimicrobial modification was significantly shorter in the multiplex PCR arm (23.2 vs. 64.5 h; P < 0.001). This was consistent across gram-negative (30.5 vs. 77.1 h; P < 0.001), gram-positive (22.7 vs. 53.5 h; P = 0.001), and yeast infections (2.9 vs. 27.7 h; P < 0.001). The reduction was maintained regardless of laboratory hours (regular hours: 9.3 vs. 66.7 h; off-hours: 37.5 vs. 60.5 h; P < 0.001) and intensive care unit (ICU) status (ICU: 20.5 vs. 84.8 h; P < 0.001; non-ICU: 23.4 vs. 55.5 h; P < 0.001). The multiplex PCR arm showed a lower rate of persistent bloodstream infections (5.7% vs. 11.5%, P = 0.038). No significant differences were observed in 30-day mortality or length of stay. CONCLUSIONS: Rapid multiplex PCR shortened the time to effective antimicrobial modification in patients with bloodstream infections.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kim KJ, Yoon YK, Kim JY, et al. Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial. Clin Infect Dis. 2026. PMID: 42619534. doi:10.1093/cid/ciag511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。